Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
11.89
+0.43 (3.75%)
At close: Jan 5, 2026, 4:00 PM EST
11.76
-0.13 (-1.09%)
After-hours: Jan 5, 2026, 7:47 PM EST
Avantor Market Cap
Avantor has a market cap or net worth of $8.11 billion as of January 5, 2026. Its market cap has decreased by -46.56% in one year.
Market Cap
8.11B
Enterprise Value
11.71B
1-Year Change
-46.56%
Ranking
Category
Stock Price
$11.89
Market Cap Chart
Since May 17, 2019, Avantor's market cap has increased from $4.93B to $8.11B, an increase of 64.52%. That is a compound annual growth rate of 7.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 7.81B | - |
| Dec 31, 2025 | 7.81B | -45.51% |
| Dec 31, 2024 | 14.34B | -7.13% |
| Dec 29, 2023 | 15.44B | 8.60% |
| Dec 30, 2022 | 14.22B | -44.64% |
| Dec 31, 2021 | 25.68B | 57.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.21B |
| Johnson & Johnson | 488.92B |
| AbbVie | 389.07B |
| UnitedHealth Group | 309.92B |
| AstraZeneca | 280.48B |
| Novartis AG | 266.00B |
| Merck & Co. | 265.80B |
| Novo Nordisk | 241.55B |